http://orcid.org/0000-0003-1272-3436
References
- Xu XR, Liu CQ, Feng BS, et al. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. WJG. 2014;20(12):3255–3264.
- Strober W, Zhang F, Kitani A, et al. Proinflammatory cytokines underlying the inflammation of Crohn's disease. Curr Opin Gastroenterol. 2010;26(4):310–317.
- Weaver CT, Hatton RD. Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol. 2009;9(12):883–889.
- Giuffrida P, Caprioli F, Facciotti F, et al. The role of interleukin-13 in chronic inflammatory intestinal disorders. Autoimmun Rev. 2019;18(5):549–555.
- Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol. 2015;135(3):626–635.
- Kuenzig EM, Bishay K, Leigh R, et al. C0-occurrence of asthma and the inflammatory bowel diseases: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2018;9(9):188.
- Pugh SM, Rhodes J, Mayberry JF, et al. Atopic disease in ulcerative colitis and Crohn’s disease. Clin Exp Allergy. 1979;9(3):221–223.
- Brignola C, Miniero M, Campieri G, et al. Dietary allergy evaluated by PRIST and RAST in inflammatory bowel disease. Hepatogastroenterology. 1986;33(3):128–130.
- Mekkel G, Barta Z, Ress Z, et al. Increased lgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases. Orv Hetil. 2005;146(17):797–802.
- Therkelsen SP, Hetland G, Lyberg T, et al. Effect of a medicinal agaricus blazei murill-based mushroom extract, AndoSan™, on symptoms, fatigue and quality of life in patients with ulcerative colitis in a randomized single-blinded placebo controlled study. PLoS One. 2016;11(3):e0150191.
- Therkelsen SP, Hetland G, Lyberg T, et al. Effect of the medicinal Agaricus blazei murill-based mushroom extract, AndoSanTM, on symptoms, fatigue and quality of life in patients with Crohn's disease in a randomized single-blinded placebo controlled study. PLoS One. 2016;11(7):e0159288.
- Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980;1(8167):514.
- Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989;298(6666):82–86.
- Olsen I, Wiker G, Johnson E, et al. Elevated antibody responses in patients with Crohn′s disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis. Scand J Immunol. 2001;5(2):198–203.
- Ellertsen LK, Storla DG, Diep LM, et al. Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy. BMC Infect Dis. 2009;9(1):100.